Study of MEDI0382 in combination with Dapagliflozin and metformin in overweight/Obese Participants with Type 2 Diabetes

Trial Identifier: D5670C00007
Sponsor: MedImmune, LLC
NCTID:: NCT03444584
Start Date: May 2018
Primary Completion Date: December 2018
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Hungarian Translation
German Translation

Trial Locations

Country Location
Germany Magdeburg, Germany, 39120
Germany Mannheim, Germany, 68167
Germany Mönchengladbach, Germany, 41061
Germany München, Germany, 81241
Hungary Balatonfüred, Hungary, 8230
Hungary Debrecen, Hungary, 4031
Hungary Miskolc, Hungary, 3529
Hungary Szeged, Hungary, 6720
United Kingdom Dundee, United Kingdom, DD1 9SY
United Kingdom Liverpool, United Kingdom, L7 8XP
United Kingdom Manchester, United Kingdom, M13 9NQ
United Kingdom Manchester, United Kingdom, M13 9WL
United Kingdom Rotherham, United Kingdom, S65 1DA
United Kingdom Swansea, United Kingdom, SA2 8PP